In particular, in the year 2023, the RORs of the pancreatitis risk with TNF inhibitors are given by ROR = 1.86 (95% CI, 1.62, 2.12) for IFX, ROR = 1.24 (95% CI, 1.08, 1.42) for ADA, ROR = 1.64 (95% CI, 1.26, 2.12) for GOL, ROR = 1.16 (95% CI, 0.93, 1.45) for CTZ, and ROR = 1.32 (95% CI, 1.06, 1.63) for ETN. This evidence concerns the gene ADA and pancreatitis.